Abbott's FreeStyle® Libre 2 iOS App Cleared in U.S., Providing a Seamless Digital Experience to Simplify Diabetes Management - Aug 2, 2021

Abbott announced today that the U.S. Food and Drug Administration (FDA) has cleared the FreeStyle® Libre 2 iOS application for use with compatible iPhones1, providing a comprehensive digital

FreeStyle Libre 2 System, Healthcare Professionals

FreeStyle Libre 3: Guide to Cost and Functions - GoodRx

FreeStyle Libre 3: Guide to Cost and Functions - GoodRx

FreeStyle Libre 2 System

Abbott FreeStyle Libre 2 iOS App Receives FDA Approval - JDRF

Download the FreeStyle Libre 2 App & LibreLink App

Abbott's Freestyle® Libre 2 IOS App Cleared In U.S., Providing a Seamless Digital Experience to Simplify Diabetes Management

Wearable Electrochemical Glucose Sensors in Diabetes Management: A Comprehensive Review

424B4

Download the FreeStyle Libre 2 App & LibreLink App

iOS 17 Could Break Crucial Diabetic Glucose Monitor Alerts, Manufacturer Warns

Abbott's FreeStyle Libre 2 iOS App Cleared in U.S., Providing a Seamles's Digital Experience to Simplify Diabetes Management

Download the FreeStyle Libre 2 App & LibreLink App

What Is Continuous Glucose Monitoring? (CGM)